Low Levels of Quantified MGMT Methylation Status Impart Positive Impact on Survival

International Journal of Radiation Oncology Biology Physics - Netherlands
doi 10.1016/j.ijrobp.2019.06.2311
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Personalized Treatment Strategies in Glioblastoma: MGMT Promoter Methylation Status

OncoTargets and Therapy
OncologyPharmacology
2013English

MGMT Methylation Status: The Advent of Stratified Therapy in Glioblastoma?

Disease Markers
BiochemistryMedicineClinical BiochemistryMolecular BiologyGenetics
2007English

Sensitivity Analysis of the MGMT-STP27 Model and Impact of Genetic and Epigenetic Context to Predict the MGMT Methylation Status in Gliomas and Other Tumors

Journal of Molecular Diagnostics
Forensic MedicinePathologyMolecular Medicine
2016English

MGMT Methylation Correlates With Melphalan Pelvic Perfusion Survival in Stage III Melanoma Patients

Melanoma Research
DermatologyCancer ResearchOncology
2017English

Local Delivery of Temozolomide via a Biologically Inert Carrier (Temodex) Prolongs Survival of Glioma Patients Irrespectively of the MGMT Methylation Status

Neoplasma
Cancer Research
2019English

18f-FDG-Pet-Based Radiomics Signature Predicts MGMT Promoter Methylation Status in Primary Diffuse Glioma

Cancer Imaging
Nuclear MedicineRadiologyUltrasound TechnologyOncologyRadiologicalImagingMedicine
2019English

Pyrosequencing Quantified Methylation Level of BRCA1 Promoter as Prognostic Factor for Survival in Breast Cancer Patient

Oncotarget
Oncology
2016English

Continuing the Search for MR Imaging Biomarkers for MGMT Promoter Methylation Status: Conventional and Perfusion MRI Revisited

Neuroradiology
Nuclear MedicineRadiologyCardiologyNeurologyCardiovascular MedicineImaging
2011English

The Predictive but Not Prognostic Value of MGMT Promoter Methylation Status in Elderly Glioblastoma Patients: A Meta-Analysis

PLoS ONE
Multidisciplinary
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy